GSK Malaysia

GSK’s Arexvy Is A Vaccine Approved To Protect Older Adults From Respiratory Syncytial Virus (RSV) Disease In Malaysia

GlaxoSmithKline Pharmaceutical Sdn Bhd (GSK) today announced that Arexvy (MAL24086007ARZ) has been approved in Malaysia for RSV, a common respiratory… Read More

8 months ago

GSK Malaysia Launches Second Phase Of #Giveback Campaign In Conjunction With World Environment Day, Championing Responsible Disposal Of Medical Waste

GSK Malaysia is taking the lead in promoting responsible disposal of medical waste with the second phase of its nationwide… Read More

2 years ago

This website uses cookies.